Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
By Maggie Fick and Bhanvi Satija LONDON, Feb 6 (Reuters) - Hims & Hers' gambit to sell a $49 compoun...
6th February, 2026
By Maggie Fick and Bhanvi Satija LONDON, Feb 6 (Reuters) - Hims & Hers' gambit to sell a $49 compoun...
6th February, 2026
By Jacob Gronholt-Pedersen COPENHAGEN, Feb 6 (Reuters) - Shares in Danish drugmaker Novo Nordisk gai...
6th February, 2026
Feb 5 (Reuters) - Danone is recalling more than 120 batches of infant formula in Austria due to poss...
5th February, 2026
By Maggie Fick LONDON, Feb 5 (Reuters) - Novo Nordisk CEO Mike Doustdar was in a meeting with invest...
5th February, 2026
COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk said on Thursday it would take legal action against Hims...
5th February, 2026
NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will begin offering copie...
5th February, 2026
By Maggie Fick, Jacob Gronholt-Pedersen and Bhanvi Satija LONDON, Feb 4 (Reuters) - Danish obesity d...
4th February, 2026
Feb 4 (Reuters) - European shares were muted on Wednesday as losses in Novo Nordisk offset strength...
4th February, 2026
COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Wednesday that the price reduct...
4th February, 2026

MADRID, Feb 2 (Reuters) - A hospital in Barcelona said on Monday it had performed a pioneering facia...
2nd February, 2026
Feb 2 (Reuters) - Sanofi has breached the UK pharma code of practice with unsubstantiated claims tha...
2nd February, 2026
By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) - The long-held Wall Street e...
2nd February, 2026